Daptomycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 16729-435

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 16729-435). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Vial Carton)

Daptomycin is a medication that comes in a single-dose vial containing 500 mg of powder that must be refrigerated. It is used for intravenous infusion and needs to be reconstituted with 0.9% sodium chloride injection. The package insert provides instructions for reconstitution and complete information about the dosage and administration of the medicine. It is important to visually inspect the medicine for particulate matter before administration. The manufacturer and the distributor of the product are identified on the label.*

FDA Label Image

Principal Display Panel (Vial label)

This text is a description of a medication called Daptomycin for Injection. The medication comes in a single-dose vial with 500 mg per vial and is for intravenous infusion. The medication must be refrigerated and any unused portion should be discarded. The vial should be reconstituted with 10 mL 0.9% Sodium Chloride Injection. The package insert should be consulted for complete information on dosage and administration. The medication is manufactured for Accord Healthcare, Inc., located in Durham, NC and manufactured by Intas Pharmaceuticals Limited located in Ahmedabad-382 210, INDIA. Lot and EXP information is included.*

FDA Label Image

Chemical Structure (Daptomycin For Inj Stru)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.